Phaarmasia shareholders pass all resolutions at 45th AGM

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • All four ordinary resolutions at Phaarmasia's 45th AGM on September 25, 2026 were passed with requisite majority
  • Total votes polled stood at 80.2151% of outstanding shares for Resolutions 1, 2, and 3, and 80.1960% for Resolution 4
  • Resolution 1 (adoption of FY26 financial statements) received 99.9944% votes in favour
  • Resolution 4 (increase in remuneration of Whole-time Director) received 99.9988% votes in favour
  • Scrutinizer's report was submitted on September 29, 2026, confirming all resolutions passed
powered bylight_fuzz_icon
51892881

*this image is generated using AI for illustrative purposes only.

Phaarmasia Ltd confirmed that shareholders approved all four resolutions at its 45th Annual General Meeting held on September 25, 2026, with the Scrutinizer's report submitted on September 29, 2026.

The AGM was conducted via Video Conferencing and other Audio-Visual Means. As on the record date of September 18, 2026, the total number of shareholders stood at 20,364. Of these, 2 promoter group members and 43 public shareholders attended through video conferencing. Voting was facilitated through remote e-voting, which remained open from September 22, 2026 at 9:00 am to September 24, 2026 at 5:00 pm, followed by venue e-voting during the AGM. Mr. NVSS Suryanarayana Rao, Practicing Company Secretary (Membership No. 5868, Certificate of Practice No. 2886), served as the Scrutinizer.

Key resolutions passed

All four ordinary resolutions were approved with requisite majority. The resolutions covered adoption of audited financial statements for FY26, reappointment of Ms. Rashmi Vinay Sapte as Director, approval of related party transactions, and an increase in remuneration for Whole-time Director Mr. Yallapragada Naga Bhaskara Rao.

Consolidated voting results

The table below presents the consolidated e-voting outcome across all four resolutions:

Resolution Total shares Votes polled % polled Votes in favour Votes against % in favour
1. Adoption of financial statements 6826960 5476256 80.2151% 5475950 306 99.9944%
2. Reappointment of Ms. Rashmi Vinay Sapte 6826960 5476256 80.2151% 5475920 336 99.9939%
3. Related party transactions 6826960 5476256 80.2151% 5475920 336 99.9939%
4. Increase in remuneration of Whole-time Director 6826960 5474952 80.1960% 5474884 68 99.9988%

Resolution-wise shareholder participation

For Resolutions 1 and 2, the promoter and promoter group cast 5,018,732 votes entirely in favour via e-voting, representing 100% of their holding. Public institutions holding 3,960 shares cast no votes across all resolutions. Public non-institutional shareholders polled 457,524 votes for Resolutions 1 and 2, with 457,218 votes in favour of Resolution 1 and 457,188 in favour of Resolution 2.

For Resolution 3 on related party transactions, the promoter group was noted as interested in the agenda. The promoter group cast 5,018,732 votes in favour, while public non-institutional shareholders cast 457,188 votes in favour and 336 against. For Resolution 4 on remuneration, public non-institutional shareholders cast 456,152 votes in favour via remote e-voting, with 1 additional vote cast against through venue e-voting, resulting in a total of 68 votes against.

Governance and attendance

Mr. Maneesh Sapte chaired the meeting, confirming requisite quorum under Section 103 of the Companies Act, 2013. The following directors were present:

Name Role
Mr. Y.N. Bhaskar Rao Whole-time Director
Mr. Maneesh Ramakant Sapte Director
Mr. Vinay Ramakant Sapte Director
Ms. Rashmi Vinay Sapte Director
Mr. Pravin Mohandas Hegde Independent Director
Mr. Ajit Gopal Jamkhandikar Independent Director

Key personnel in attendance included CFO Mr. Eswara Prasad Rao Nagineni, Company Secretary Ms. Urvashi Bhatia, and Statutory Auditor Mr. S. S. Prakash. Voting results were disclosed to the stock exchanges and published on the company website upon receipt of the Scrutinizer's report.

Historical Stock Returns for Phaarmasia

1 Day5 Days1 Month6 Months1 Year5 Years
-1.73%+1.15%-7.94%0.0%+149.86%+236.52%

How will the approved increase in remuneration for the Whole-time Director impact Phaarmasia's operating expenses and profit margins in FY27?

What specific strategic initiatives are planned to drive growth, given the adoption of the FY26 audited financial statements?

Will the approval of related party transactions lead to any changes in the company's supply chain or operational dependencies?

Phaarmasia sets Sept 25 AGM; approves FY26 profit of ₹1,757.3 lakh

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Phaarmasia schedules 45th AGM for September 25, 2026, via VC/OAVM with e-voting enabled.
  • FY26 net profit turned positive at ₹1,757.28 lakh vs loss of ₹158.94 lakh in FY25.
  • Revenue from operations grew 93.7% YoY to ₹4,720.75 lakh.
  • Shareholders to approve ₹100 crore limit for related party transactions for FY27.
  • Remuneration hike for Whole-time Director to ₹38.5 lakh per annum proposed.
powered bylight_fuzz_icon
49995331

*this image is generated using AI for illustrative purposes only.

Phaarmasia Limited has scheduled its 45th Annual General Meeting (AGM) for Friday, September 25, 2026, at 4:00 pm. The meeting will be conducted through Video Conferencing and Other Audio Visual Means (VC & OAVM). The company is enabling remote e-voting for shareholders from September 22 to September 24, 2026.

The primary agenda includes adopting the audited financial statements for FY26, which reported a net profit of ₹1,757.28 lakh, a significant turnaround from a net loss of ₹158.94 lakh in the previous year. Revenue from operations nearly doubled to ₹4,720.75 lakh from ₹2,436.88 lakh.

Key Resolutions

Shareholders will vote on several special business items:

  • Related Party Transactions: Approval for transactions with related parties, including Maneesh Pharmaceuticals Limited and Svizera Health Private Limited, up to an aggregate value of ₹100 crore for FY27.
  • Director Remuneration: Increase in the remuneration of Whole-time Director Mr. Naga Bhaskara Rao Yallapragada to ₹38.5 lakh per annum.
  • Reappointment: Reappointment of Mrs. Rashmi Vinay Sapte as a director upon retirement by rotation.

Financial Highlights

Metric FY26 FY25 Change
Revenue from Operations ₹4,720.75 lakh ₹2,436.88 lakh +93.7%
Net Profit After Tax ₹1,757.28 lakh (₹158.94 lakh) Turnaround
Profit Before Tax ₹2,138.78 lakh (₹160.27 lakh) Turnaround

The substantial profit increase was driven largely by an exceptional item: a ₹1,898.70 lakh profit on the sale of land and building. Excluding this one-time gain, the operational profit before tax stood at ₹240.09 lakh, compared to an operational loss of ₹160.27 lakh in FY25.

What the Numbers Show

While the headline net profit reflects a strong turnaround, it is heavily influenced by non-operational gains. The ₹1,898.70 lakh exceptional gain constitutes approximately 88% of the total pre-tax profit. Operational revenue growth of 93.7% indicates improved business activity, but core profitability remains modest relative to the top-line expansion.

Voting Eligibility and Resources

Shareholders holding shares as of the cut-off date, Friday, September 18, 2026, are eligible to vote. The notice for the 45th AGM and the printed Annual Report for FY26 have been uploaded to the company’s website. Urvashi Bhatia, Company Secretary and Compliance Officer, issued the intimation to BSE Limited.

Historical Stock Returns for Phaarmasia

1 Day5 Days1 Month6 Months1 Year5 Years
-1.73%+1.15%-7.94%0.0%+149.86%+236.52%

How will the approval of up to ₹100 crore in related party transactions with Maneesh Pharmaceuticals and Svizera Health impact Phaarmasia's operational independence and future revenue streams?

Given that 88% of pre-tax profit came from a one-time asset sale, what specific strategic initiatives are in place to sustain core operational profitability beyond FY26?

Will the proposed remuneration increase for the Whole-time Director align with performance metrics tied to organic revenue growth rather than exceptional gains?

More News on Phaarmasia

1 Year Returns:+149.86%